February 17, 2026 / Sciad Communications / Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou ...

The global whole genome sequencing market size was valued at USD 2.63 billion in 2025 and is predicted to hit around USD 15.96 billion by 2034, rising at a 22.2% CAGR, a study published by Towards ...

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.

Pacific Biosciences of California, Inc. ( PACB) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST Good day, and welcome to PacBio's Fourth Quarter and Full Year 2025 Earnings Conference Call. Please ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

Research shows that 77 percent of lab professionals now use public AI tools alongside their ELN. For many, this is not driven by policy decisions, but by necessity. Governed tools do not yet support ...

Jim Tananbaum, MD, Foresite Capital’s founder and CEO, and Michael Rome, PhD, the managing director who leads the firm’s therapeutics investing practice, discuss the firm’s approach to nurturing ...

Analysts expect earnings of 4 cents a share on revenue of $188.1 million, representing modest sequential improvement from the ...

Federal financing engagement -- Advanced discussions with the U.S. Export-Import Bank under the Make More in America ...

ProPhase Labs, Inc. (OTC: PRPH) ('ProPhase” or the 'Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET.

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...